Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
via Google News
The Latest on: Autism
- Recovering From PTSD After Being Bullied as Someone on the Autism Spectrumon May 11, 2020 at 5:23 pm
After that, things get a little blurry in my mind. It’s weird, because I have this near-photographic memory, and I can remember being in diapers. But ask me what happened in high school, and I have ...
- Coronavirus: Autism makes coping with lockdown 'extra hard'on May 11, 2020 at 4:45 pm
Image caption Stuart Cosgrove's son Jack has found it difficult to cope with lockdown Radio presenter Stuart Cosgrove admits lockdown has been hard on his son Jack. The bright eight-year-old has ...
- First US study of autism in adults estimates 2.2% have autism spectrum disorderon May 11, 2020 at 3:35 pm
The first US study of autism in adults estimates that 2.2% of Americans adults have an autism spectrum condition. That adds up to 5.4 million people age 18 and older, or about 1 in 45 people, the US ...
- Baby's sleep problems could signal autism, study suggestson May 11, 2020 at 2:30 pm
Sleep problems in baby's first year may affect growth of the hippocampus and may also precede an autism diagnosis, researchers say.
- Baby's Sleep Issues Could Sometimes Signal Autism: Studyon May 11, 2020 at 9:45 am
Babies who have disrupted sleep, as many with autism do, may experience delayed brain development, a new study suggests. Sleep problems in baby's first year may affect growth of the hippocampus and ...
- Many Kids With Autism Had Sleep Problems as Infantson May 10, 2020 at 8:03 am
In a new study of more than 400 young children, those who were diagnosed with autism were more likely to have had difficulty falling asleep as infants. This sleep difficulty was associated with ...
- Coronavirus: Second North East Autism Society worker dieson May 9, 2020 at 4:12 am
A woman has become the second person at an autism charity to die after contracting coronavirus. Sue Gargett, 53, had been an "invaluable" worker at the North East Autism Society (NEAS) before her ...
- Prenatal Antidepressants Not Linked To Child’s Risk For Autismon May 8, 2020 at 1:40 pm
A new study out of the University of Texas at Austin finds no link between a child’s risk for autism and a pregnant mom’s use of antidepressant medications. Dr. Jeffrey Newport, director of the ...
- Aluminium in human brain tissue from donors without neurodegenerative disease: A comparison with Alzheimer’s disease, multiple sclerosis and autismon May 8, 2020 at 7:16 am
A burgeoning number of studies are demonstrating aluminium in human brain tissue. While research has both quantified and imaged aluminium in human brain tissue in neurodegenerative and ...
- Study Links Key Imprinted Genes to Autismon May 8, 2020 at 1:48 am
Since the turn of the century, circumstantial evidence has accumulated for the role of imprinted genes (those only expressed from one parent) in mental illnesses such as Autism Spectrum Disorder (ASD) ...
via Bing News